Ieso Digital Health
Ieso Digital Health is a company.
Active
Updated: ·
Financial History
Total Raised
N/A
Valuation
N/A
Leadership Team
Key people at Ieso Digital Health.
Ieso Digital Health is a company.
Key people at Ieso Digital Health.
Key people at Ieso Digital Health.
Ieso Digital Health is a Cambridge-based digital health company specializing in AI-powered mental healthcare solutions, primarily delivering evidence-based cognitive behavioral therapy (CBT) via text-based teletherapy platforms and apps.[1][2][3] It serves patients, the UK NHS (available to 20 million people in England and Scotland), health plans, payers, employers, and integrated care networks, addressing the global mental health crisis by scaling personalized, outcomes-measured treatment for conditions like anxiety, depression, OCD, phobias, and sleep issues.[1][2][4][6] The company solves long waiting lists and access barriers through immediate, app-based support blending CBT with data from over 815,000 hours of therapy, achieving clinical outcomes comparable to in-person care while expanding into the US market.[1][2][3][6] Growth includes treating over 145,000 patients, a $53 million Series B funding round, and recent strategic sale of non-core UK telecare services to focus on its generative AI platform, Velora.[2][3][6]
Founded in 2000 in the UK by two psychologists passionate about leveraging internet technology for mental health access, ieso began as Psychology Online and evolved through rigorous testing.[2][3] A pivotal 2009 randomized control trial published in *The Lancet* proved the efficacy of online CBT, validating their text-based, one-to-one therapy model.[3] Early traction came via NHS partnerships starting in 2011 after seed funding to build a virtual care platform, leading to milestones like treating 50,000 patients, peak concurrent treatment of 3,500 patients, and presence in 70 NHS Trusts with £7.5 million turnover by recent years.[3][4] Key leaders include CEO Kent Tangen, who now steers US expansion and AI focus, building on a dataset from 700,000+ therapy hours analyzed for AI insights.[1][4][6]
Ieso rides the convergence of AI, digital therapeutics, and mental health crises, amplified by post-pandemic demand for scalable care amid NHS waitlists and US payer pressures.[1][4][6] Timing aligns with accelerating AI adoption in healthcare—mental health as a prime use case—fueled by generative AI advancements and data privacy regulations enabling secure, de-identified datasets.[2][6] Market forces like rising employer wellness needs, payer incentives for cost-effective outcomes, and evidence from 145,000+ patients position ieso to license its platform internationally, influencing ecosystems by publishing research, partnering with health systems, and embedding lived experience in product development.[2][3][6] This data-driven approach challenges fragmented telehealth, pushing industry standards toward AI-augmented, personalized care at national scale.[4]
Ieso is poised to dominate AI-powered mental health with Velora's SaaS integration, targeting US health plans and global payers for rapid scaling amid a market hungry for effective, low-cost alternatives to human-only therapy.[6] Trends like AI real-time therapist support, multimodal data analysis, and regulatory tailwinds for digital therapeutics will accelerate growth, potentially licensing tech worldwide while deepening NHS entrenchment.[2][4][6] Influence may evolve from NHS waitlist reliever to ecosystem shaper, publishing breakthroughs that redefine mental health specificity and access—unlocking a future where clinical data truly transforms global care, as envisioned by its psychologist founders.[3]
